PR 34265 - Fragment Analyzer
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Agilent Technologies for the purchase of Fragment Analyzer from Advanced Analytical. The platform is required for the preparation of DNA libraries for illumina sequencing as per our standard operative protocol. The data generated by this unit is easily imported into our robotic units for downstream molecular processing. This is the only instrument that can be fully automated with our Biomek GHOST Workstation. Agilent Technologies is the manufacturer and only provider.. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within ten (10) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at kpy3@cdc.gov by Noon 30 June 2019
Keeshia L Pettis, Contracts Specialist II, Phone 7707294280, Email kpy3@cdc.gov
